Paper icon

Choosing the right target in drug discovery
Whether aiming for first-in-class or best-in-class, pharmaceutical companies now have expanded options

Brought to you by Clarivate Analytics


Drug discovery has historically centered around a relatively small subset of “druggable” targets. But, in the race to be first-in-class, multiple companies pursue the same targets despite overcrowded markets.  This means that to gain market share, later entrants will need to be the “best-in-class.”  Now, data and analytics provide a better way to identify potential targets.

In this eBook, we explore options and offer data-driven perspectives for how companies can take a fresh approach to identifying potential drug targets.

Key Learning Objective

  • Visualize the right connections between a target and an indication
  • Stay ahead of the competition
  • Understand the requirement for your drug to be deemed best in class
  • Confidently aim for first-in-class or best-in-class using insightful data

Brought to you by: 
Clarivate Analytics

Choosing the right target in drug discovery

Please complete the form to download the whitepaper.

Copyright © 2024 American Chemical Society | 1155 Sixteenth Street NW | Washington, DC 20036 | View our Privacy Policy